Financials • Specialty Insurers
$273.01 ▲ +4.50
(+1.68%)
MKT CAP: $515.4M • VOL: 55.7K
52W L $210 52W H $310
ROARABLE / RQD
C+ • 69/100
PIOTROSKI
5 / 9
ITIC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $40.9M | $35.1M | $36.3M |
| YoY Revenue Growth % | +16.4% | -3.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $35.2M | $31.1M | $21.7M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $30.9M | $29.8M | $7.4M |
| Capital Expenditures (CapEx) | $5.6M | $7.4M | — |
| Free Cash Flow (FCF) | $25.4M | $22.4M | $7.4M |
| FCF Margin % | 62.0% | 63.8% | 20.4% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $20.8M | $24.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $268.3M | $251.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ITIC.